What staging system is related to Colon/Rectum cancers?

The Dukes Staging System is specifically designed for staging colorectal cancers, which include both colon and rectal cancers. This system classifies cancer based on the extent of disease spread, helping to determine the prognosis and treatment options for patients. The Dukes Staging System categorizes cancer into four stages:

• Duke's A: Tumor confined to the bowel wall.

• Duke's B: Tumor has penetrated through the bowel wall but has no lymph node involvement.

• Duke's C: Tumor has spread to regional lymph nodes but not distant sites.

• Duke's D: Distant metastasis is present.

This clear stratification makes it valuable in clinical settings for assessing patient outcomes and tailoring treatments.

The other staging systems mentioned serve different types of cancer. The FIGO Staging System primarily pertains to gynecological cancers, while the Gleason Staging System is used for prostate cancer. The BRTC Staging System does not refer to a widely recognized or established staging system for colorectal cancers. Thus, the Dukes Staging System is the most appropriate choice for staging colon and rectal cancers, emphasizing its relevance and application in oncology.